BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29213033)

  • 1. [Epigenetic modifications of chromatin in epilepsy: a potential mechanism of pharmacoresistance?].
    Sokhranyaeva LS; Aniol VA; Gulyaeva NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9. Vyp. 2):17-21. PubMed ID: 29213033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The methylation hypothesis: do epigenetic chromatin modifications play a role in epileptogenesis?
    Kobow K; Blümcke I
    Epilepsia; 2011 Jul; 52 Suppl 4():15-9. PubMed ID: 21732935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The methylation hypothesis of pharmacoresistance in epilepsy.
    Kobow K; El-Osta A; Blümcke I
    Epilepsia; 2013 May; 54 Suppl 2():41-7. PubMed ID: 23646970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Epigenetics of Epilepsy and Its Progression.
    Hauser RM; Henshall DC; Lubin FD
    Neuroscientist; 2018 Apr; 24(2):186-200. PubMed ID: 28468530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics and epilepsy.
    Pulido Fontes L; Quesada Jimenez P; Mendioroz Iriarte M
    Neurologia; 2015 Mar; 30(2):111-8. PubMed ID: 24851699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics and Epilepsy.
    Henshall DC; Kobow K
    Cold Spring Harb Perspect Med; 2015 Oct; 5(12):. PubMed ID: 26438606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular hallmarks of epigenetic effects mediated by antiepileptic drugs.
    Navarrete-Modesto V; Orozco-Suárez S; Feria-Romero IA; Rocha L
    Epilepsy Res; 2019 Jan; 149():53-65. PubMed ID: 30476813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetics of Epileptogenesis-Evoked Upregulation of Matrix Metalloproteinase-9 in Hippocampus.
    Zybura-Broda K; Amborska R; Ambrozek-Latecka M; Wilemska J; Bogusz A; Bucko J; Konopka A; Grajkowska W; Roszkowski M; Marchel A; Rysz A; Koperski L; Wilczynski GM; Kaczmarek L; Rylski M
    PLoS One; 2016; 11(8):e0159745. PubMed ID: 27505431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of epigenetic inheritance.
    Martin C; Zhang Y
    Curr Opin Cell Biol; 2007 Jun; 19(3):266-72. PubMed ID: 17466502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between different epigenetic modifications and mechanisms.
    Murr R
    Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the dynamic epigenome: from histone modifications towards self-organizing chromatin.
    Rohlf T; Steiner L; Przybilla J; Prohaska S; Binder H; Galle J
    Epigenomics; 2012 Apr; 4(2):205-19. PubMed ID: 22449191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation dynamics in aging: how far are we from understanding the mechanisms?
    Ciccarone F; Tagliatesta S; Caiafa P; Zampieri M
    Mech Ageing Dev; 2018 Sep; 174():3-17. PubMed ID: 29268958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic genes and epilepsy - emerging mechanisms and clinical applications.
    Van Loo KMJ; Carvill GL; Becker AJ; Conboy K; Goldman AM; Kobow K; Lopes-Cendes I; Reid CA; van Vliet EA; Henshall DC
    Nat Rev Neurol; 2022 Sep; 18(9):530-543. PubMed ID: 35859062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking epigenetics to lipid metabolism: focus on histone deacetylases.
    Ferrari A; Fiorino E; Giudici M; Gilardi F; Galmozzi A; Mitro N; Cermenati G; Godio C; Caruso D; De Fabiani E; Crestani M
    Mol Membr Biol; 2012 Nov; 29(7):257-66. PubMed ID: 23095054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies.
    Boison D; Rho JM
    Neuropharmacology; 2020 May; 167():107741. PubMed ID: 31419398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-talk among epigenetic modifications: lessons from histone arginine methylation.
    Molina-Serrano D; Schiza V; Kirmizis A
    Biochem Soc Trans; 2013 Jun; 41(3):751-9. PubMed ID: 23697934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone onco-modifications.
    Füllgrabe J; Kavanagh E; Joseph B
    Oncogene; 2011 Aug; 30(31):3391-403. PubMed ID: 21516126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure.
    Greco CM; Condorelli G
    Nat Rev Cardiol; 2015 Aug; 12(8):488-97. PubMed ID: 25962978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic modification in chromatin machinery and its deregulation in pediatric brain tumors: Insight into epigenetic therapies.
    Maury E; Hashizume R
    Epigenetics; 2017 May; 12(5):353-369. PubMed ID: 28059591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical systems approaches for the analysis of histone modification readout.
    Soldi M; Bremang M; Bonaldi T
    Biochim Biophys Acta; 2014 Aug; 1839(8):657-68. PubMed ID: 24681439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.